Three weeks of radiation therapy instead of five yields comparable results for patients with non-metastatic soft tissue sarcoma Isra Zaman7 Nov 2022 9:00 AM ISTA major side effect of pre-operative radiation therapy in patients with non-metastatic STS is an increased risk of wound-healing complications after...
Health Bulletin 5/November/2022 Roshni Dhar5 Nov 2022 5:06 PM ISTHere are the top health news for the day:MCC adds 90 MBBS, 66 BSc Nursing seats to Round 2 NEET counselling, detailsThrough a recent notice, MCC...
Pfizer Elranatamab gets USFDA Breakthrough Therapy Designation for Relapsed or Refractory Multiple Myeloma Ruchika Sharma4 Nov 2022 3:00 PM ISTNew York: Pfizer Inc. has announced that its investigational cancer immunotherapy, elranatamab, has received Breakthrough Therapy Designation from the...
AI may help identify melanoma survivors at high risk of cancer recurrence Dr. Kamal Kant Kohli3 Nov 2022 5:00 AM ISTMost deaths from melanoma-the most lethal form of skin cancer-occur in patients who were initially diagnosed with early-stage melanoma and then later...
Diverticular disease associated with cancer outside gastrointestinal tract Dr. Kamal Kant Kohli2 Nov 2022 8:00 PM ISTDiverticular disease can present through gastrointestinal bleeding, but also through diverticulitis when patients may have fever, nausea and abdominal...
Medical Bulletin 31/October/2022 Isra Zaman31 Oct 2022 4:16 PM ISTHere are the top medical news for the day:Repotrectinib could be effective for treating ROS1 positive NSCLC: TRIDENT-1 trialRepotrectinib has been...
Repotrectinib could be effective for treating ROS1 positive NSCLC: TRIDENT-1 trial Isra Zaman31 Oct 2022 9:30 AM ISTRepotrectinib has been designed to help patients with NSCLC that have a genetic rearrangement in their tumour cells called ROS1positive that can...
Experimental drug shows evidence of anti-cancer activity Isra Zaman31 Oct 2022 9:00 AM IST A new drug that inhibits an enzyme playing a crucial role in cell division and growth has shown signs of anti-cancer activity with manageable...
Merck lifts full-year forecast as cancer immunotherapy Keytruda sales soar Ruchika Sharma29 Oct 2022 1:30 PM ISTMerck has been looking to pursue deals to protect itself from an eventual revenue loss as Keytruda patents begin to expire toward the end of the...
Targeted lung cancer drug repotrectinib shows promise in TRIDENT-1 trial Dr. Kamal Kant Kohli29 Oct 2022 4:45 AM ISTResearchers have found in TRIDENT-1 trial that targeted drug repotrectinib could help treat patients with a certain type of non-small cell lung...
Short bursts of vigorous activity associated with increased longevity Dr. Kamal Kant Kohli29 Oct 2022 4:00 AM ISTResearchers have found in a new study that short bursts of vigorous activity were linked with increased longevity. Two minute bursts of vigorous...
Medical Bulletin 28/October/2022 Isra Zaman28 Oct 2022 5:00 PM ISTHere are the top medical news for the day:Specific alterations in the BRAF gene found that may affect treatment and survival response in adult brain...
